Better Imaging for Cancer Detection
Quantitative in-vivo and clinical imaging (Boppart)
This project develops new imaging methods to find cancer more quickly and accurately without needing special dyes or markers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-11162334 on NIH RePORTER |
What this research studies
Our goal is to bring advanced imaging technologies from the lab directly to patients to improve how we find, diagnose, and keep track of diseases like cancer. Current imaging often relies on special dyes or labels, which can be costly, time-consuming, and have safety concerns. We are working on "label-free" imaging, which means we can see changes in body tissues without adding anything. This approach looks for natural signals or markers in the body that show changes in structure, chemistry, and how cells are working. This could make quantitative clinical imaging a faster and more direct alternative to current methods.
Who could benefit from this research
Good fit: Patients who need improved methods for early cancer detection or monitoring of disease progression could potentially benefit from future applications of this technology.
Not a fit: Patients whose conditions do not involve the types of tissue changes detectable by advanced optical imaging may not directly benefit from this specific technology.
Why it matters
Potential benefit: If successful, this could lead to faster, safer, and more precise ways to detect cancer and other diseases, potentially improving patient outcomes.
How similar studies have performed: While label-based optical imaging has shown potential in cancer detection, this project focuses on developing novel label-free methods to overcome current limitations.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Boppart, Stephen a — University of Illinois at Urbana-Champaign
- Study coordinator: Boppart, Stephen a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.